Clinical Analysis of Uterine Papillary Serous Carcinoma and Uterine Clear Cell Carcinoma
-
摘要:
目的 分析子宫内膜乳头状浆液性腺癌(UPSC)与透明细胞癌(UCCC)的临床特点及预后。 方法 回顾性分析天津市中心妇产科医院2004年4月至2012年7月收治的41例UPSC与19例UCCC临床资料。 结果 UPSC完全手术分期24例, 早期(仅Ⅰ期)9例, 晚期(Ⅲ、Ⅳ期)15例。UCCC完全手术分期10例, 早期(仅Ⅰ期)6例, 晚期(Ⅲ、Ⅳ期)4例。单因素分析显示: 脉管浸润、腹水/腹腔冲洗液细胞学阳性及淋巴结转移者总生存期(OS)较短; 脉管浸润、肌层浸润、腹水/腹腔冲洗液细胞学阳性者无病生存期(DFS)较短。多因素Cox回归分析显示: 淋巴结转移、腹水/腹腔冲洗液细胞学阳性者的患者OS较短; 脉管浸润、腹水/腹腔冲洗液细胞学阳性者的患者DFS较短。 结论 UPSC确诊时多为晚期, 预后差。治疗强调全面手术分期, 脉管浸润、肌层浸润、腹水/腹腔冲洗液及淋巴结转移与预后相关。 -
关键词:
- 子宫内膜乳头状浆液性腺癌 /
- 透明细胞癌 /
- 治疗 /
- 预后分析
Abstract:Objective This study was designed to analyze the clinico-pathological features and prognostic factors of uterine papillary serous carcinoma (UPSC) and uterine clear cell carcinoma (UCCC). Methods A retrospective analysis of 41 UPSC patients and 19 UCCC patients who were treated in Tianjin Central Hospital of Gynecology Obstetrics between April 2004 and July 2012 was performed. Results Among the UPSC patients, 24 were subjected to comprehensive surgical staging, which revealed that 9 (37.5%) and 15 (62.5%) patients exhibited early- (only I) and advanced-stage (II1/IV) carcinoma, respectively. For the UCCC patients, 10 were subjected to comprehensive surgical staging, which showed that 6 (60%) and 4 (40%) patients manifested early- (only I) and advanced-stage (IU/IV) carcinoma, re- spectively. Univariate analysis results showed that vascular invasion, positive ascites/peritoneal washing cytology, and lymph node metastasis were the important prognostic factors for overall survival (OS). For disease-free survival (DFS), vascular invasion, myometrial invasion, and positive ascites/peritoneal washing cytology were the important prognostic factors. Multivariate analysis results revealed that vascular invasion and positive ascites/peritoneal washing cytology were the important prognostic factors for OS, whereas positive ascites/peritoneal washing cytology and lymph node metastasis were the important prognostic factors for DFS. Conclusions Poor prognosis of patients was observed when most of them were initially diagnosed with UPSC, particularly when the diagnosis revealed advanced-stage carcinoma. Thus, comprehensive surgical staging is recommended. Furthermore, vascular invasion, myometrial invasion, and lymph node metastasis as well as the result of ascites/peritoneal washings should be considered during prognosis. -
表 1 手术病理分期 例
Table 1. Pathological staging during surgery
表 2 术后病理结果 例
Table 2. Pathological results after surgery
-
[1] Einstein MH, Frimer M, Kuo DY, et al. Phase Ⅱ trial of adjuvant pelvic radiation "sandwiched "between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma[J]. Gynecol Oncol, 2012, 124(1): 21-25. doi: 10.1016/j.ygyno.2011.10.007 [2] 任玉兰, 王华英, 沈磊, 等. 子宫内膜浆液性乳头状癌33例临床分析[J]. 中华妇产科杂志, 2006, 41(12): 817-821. doi: 10.3760/j.issn:0529-567X.2006.12.007 [3] Mendivil A, Schuler KM, Gehrig PA, et al. Non-Endometrioid Adenocarcinoma of the Uterine Corpus: A Review of Selected Histological Subtypes[J]. Cancer Control, 2009, 16(1): 46-52. doi: 10.1177/107327480901600107 [4] Viswanathan AN, Macklin EA, Berkowitz R, et al. The importance of chemotherapy and radiation in uterine papillary serous carcinoma[J]. Gynecol Oncol, 2011, 123(3): 542-547. doi: 10.1016/j.ygyno.2011.09.005 [5] Busmanis I, Ho TH, Tan SB, et al. p53 and bcl-2 Expression in Invasive and Pre-invasive Uterine Papillary Serous Carcinoma and Atrophic Endometrium[J]. Ann Acad Med Singapore, 2005, 34(7): 421-425. [6] Gupta D, Gunter MJ, Yang K, et al. Performance of Serum CA125 as a Prognostic Biomarker in Patients With Uterine Papillary Serous Carcinoma[J]. Int J Gynecol Cancer, 2011, 21(3): 529-534. doi: 10.1097/IGC.0b013e31821091b5 [7] Skaznik-Wikiel ME, Ueda SM, Frasure HE, et al. Abnormal Cervical Cytology in the Diagnosis of Uterine Papillary Serous Carcinoma: Earlier Detection of a Poor Prognostic Cancer Subtype[J]? Acta Cytol, 2011, 55(3): 255-260. doi: 10.1159/000324052 [8] Rauh-Hain JA, Growdon WB, Schorge JO, et al. Prognostic determinants in patients with stage ⅢC and Ⅳ uterine papillary serous carcinoma[J]. Gynecol Oncol, 2010, 119(2): 299-304. doi: 10.1016/j.ygyno.2010.07.010 [9] Fader AN, Drake RD, O'Malley DM, et al. Platinum/Taxane-based Chemotherapy With or Without Radiation Therapy Favorably Impacts Survival outcomes in stage I uterine papillary serous carcinoma[J]. Cancer, 2009, 115(10): 2119-2127. doi: 10.1002/cncr.24247